Trial · NCT07211802
CKM For Safe Use of SGLT2i in Type 1 Diabetes
NCT07211802, Phase 3, Not yet recruiting, University of California, San Diego
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. CKM For Safe Use of SGLT2i in Type 1 Diabetes. Trials, record NCT07211802. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07211802
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- CKM For Safe Use of SGLT2i in Type 1 Diabetes
- NCT number
- NCT07211802
- Status
- Not yet recruiting
- Phases
- Phase 3
- Enrollment
- 52 participants, estimated
- Lead sponsor
- University of California, San Diego
- Conditions
- Type 1 Diabetes (T1D)
- Interventions
- Sotagliflozin Low Dose, Sotagliflozin High Dose, Dual Continuous Glucose and Ketone Monitor
- First posted
- 2025-10-08
- Last updated
- 2026-11-04
Source ClinicalTrials.gov
Registered outcomes3
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | BHB Time Above 0.6mmol/L - 200mg | 6 weeks | Beta hydroxybutyrate (BHB) time \> 0.6 millimole per liter (mmol/L) as measured by the DGK during the 200mg dosing period in the MDI vs. HCL groups. |
| Primary | BHB Time Above 0.6mmol/L - 400mg | 6 weeks | Beta hydroxybutyrate (BHB) time \> 0.6 mmol/L as measured by the DGK during the 400mg dosing period in the MDI vs. HCL groups. |
| Secondary | BHB Time Above 0.6mmol/L - 200mg vs. 400mg | 6 weeks | Beta hydroxybutyrate (BHB) time \> 0.6 mmol/L as measured by the DGK comparing the 200mg treatment period to the 400mg treatment period. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants1
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
| Project | Title | Principal investigators | Organization | Funder | Fiscal years |
|---|---|---|---|---|---|
| U01DK143381 | Utilizing continuous ketone monitors to enable safe use of SGLT inhibitors in patients with Type 1 Diabetes | PETTUS, JEREMY H | UNIVERSITY OF CALIFORNIA, SAN DIEGO | NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES | 2025 |
Source NIH RePORTER
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07211802
GET https://conductscience.org/api/trials/v1/NCT07211802/registered